 | 
CD-NP is a novel rationally designed chimeric natriuretic peptide in clinical studies for an initial indication of acute decompensated heart failure. » More
|
|
2NTX-99 is a small molecule with anti-atherothrombotic and nitric oxide donating properties that is in pre-clinical development. » More |
 | |
- November 13, 2008 - Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results » Read
- November 3, 2008 - Nile Therapeutics to Present at Two Upcoming Investor Conferences » Read
- October 14, 2008 - Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure » Read
 |
| Event: | Lazard Capital Markets 5th Annual Healthcare Conference |
| Date: | November 19, 2008 |
| Time: | 9:00 a.m. (Presentation,) 9:30 a.m. (Breakout Meeting) |
| Location: | The St. Regis, 2 East 55th Street, New York, NY 10022 |
|
Web Site: | http://www.lazardcap.com/
|
 |
| Event: | BIO-Europe 2008 |
| Date: | November 19, 2008 |
| Time: | 12:00 pm, Presentation: Room I, Level |
| Location: | m:con Congress Center Rosengarten, Rosengartenplatz 2, 68161 Mannheim, Germany |
|
Web Site: | http://www.ebdgroup.com/bioeurope/
|
 |
| Event: | 20th Annual Piper Jaffray Health Care Conference |
| Date: | December 3, 2008 |
| Time: | 4:30 pm, Presentation: Room TBA |
| Location: | The New York Palace, 455 Madison Ave, New York, NY 10022 |
|
Web Site: | http://www.piperjaffray.com/conferences
|
|
|
